Cross-linked antioxidant nanozymes for improved delivery to CNS - Wikidata - wikimedia - TriplyDB

Cross-linked antioxidant nanozymes for improved delivery to CNS

Cross-linked antioxidant nanozymes for improved delivery to CNS

http://www.wikidata.org/entity/Q35664128

about

Nanostructures for peroxidases Bridge between neuroimmunity and traumatic brain injury Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases Polymeric Nanostructures for Imaging and Therapy Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.Agile delivery of protein therapeutics to CNS SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury Shell-crosslinked knedel-like nanoparticles induce lower immunotoxicity than their non-crosslinked analogs.Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles.Differential immunotoxicities of poly(ethylene glycol)- vs. poly(carboxybetaine)-coated nanoparticles.Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.Targeted interception of signaling reactive oxygen species in the vascular endothelium Nanocarrier: a potential tool for future antioxidant therapy.

P2860

Q26782807-AE6D4D29-CD80-4971-A821-6E25F42E3B7A Q26827612-7B2CDDAF-435A-4CDE-9BC1-2ADF5E835F72 Q27016563-AAAA0412-10BF-47A3-9689-98A79CCDA94C Q30372383-C17F6435-3617-4D8C-9CEE-4435B530E285 Q30535357-E3C929E4-9AFF-4F25-87FC-1D861017140B Q33631069-215191B5-3CB0-4427-883B-3CE572C6F5B8 Q33978310-5B843DD3-6D84-4FF7-936C-CDBE0076E7AE Q34079647-55919A87-939F-47D0-A522-50FC8604B9C0 Q34481558-C30E64E3-F89D-4900-9998-E895E06159C9 Q36035550-1F970863-8614-441E-B818-DA0D1994E103 Q36369061-66AA9E44-3430-43FF-AB8A-C45DB968C7D2 Q36392586-4AD8ED03-FF69-4886-978E-583DBDE5AE44 Q36684451-BAE41F26-E372-4DD8-BAD3-0E518ECA7831 Q37265121-6306E259-7D85-4DB3-9BE8-0927E0972529 Q37334228-5572B0CE-25AD-4BF5-B20D-7B6959041A04 Q37381547-7C96874E-701A-4308-923B-F9487C303E75 Q37672410-E01F7BA8-93EC-46B9-954B-A8947AFDFF8D Q38029695-1866857D-F4FE-4D69-9105-D19E17E268BD Q38213492-5537917A-8971-4820-94AA-76001B7BAA9F

P2860

Cross-linked antioxidant nanozymes for improved delivery to CNS

http://www.wikidata.org/entity/Q35664128

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cross-linked antioxidant nanozymes for improved delivery to CNS

@ast

Cross-linked antioxidant nanozymes for improved delivery to CNS

@en

type

label

Cross-linked antioxidant nanozymes for improved delivery to CNS

@ast

Cross-linked antioxidant nanozymes for improved delivery to CNS

@en

prefLabel

Cross-linked antioxidant nanozymes for improved delivery to CNS

@ast

Cross-linked antioxidant nanozymes for improved delivery to CNS

@en

P1433

Q35664128-E1CCEC9B-F7E2-4EB3-AC1B-64C9B540E44B

P1476

Q35664128-0E847AE9-48BB-42C9-B726-ED8FB2B24F99

P2093

Q35664128-0513387E-D46B-418B-937F-A3788E353BBD

Q35664128-2980C223-7E5A-4499-A3F6-4D3CCE86E4E0

Q35664128-3B6E173C-CDE4-48FC-B026-99F65C9CC17E

Q35664128-57D5D2B1-38D1-4D0B-B1A6-2476ADC2E0ED

Q35664128-79095AD4-A390-463A-9877-1D7EDF157BD7

Q35664128-97A9C950-65A8-427B-87D1-62B6E8FD708F

Q35664128-9CD3D4AA-4D56-46ED-AE6D-3D30C31442B7

Q35664128-BBBC9C32-1688-4FD9-8BD3-65348842CD37

Q35664128-C77E1DAF-4A00-4284-B4E0-739A650E524A

P2860

Q35664128-0743AA87-01AB-45E8-B4D4-6E9B753E89E9

Q35664128-0BB9973E-5D8A-4A25-8D09-B7FCF9409D15

Q35664128-0D247FEA-BF42-4493-9A25-27CC7BA4321D

Q35664128-11CFE1A8-3373-4127-813C-9884A1DF623A

Q35664128-21A2E783-3443-4668-8330-0AEE6F7F1402

Q35664128-25F840DF-BA1C-4598-8728-D28C5D699756

Q35664128-264AE94F-D3EF-4474-9104-9871F50F01EC

Q35664128-35806C28-84AC-48A3-8F21-86BA3EC9CBF0

Q35664128-4460F463-0290-4EE3-970E-87905C8FF483

Q35664128-511ED7A7-5796-488F-BE3A-F5259622D2E1

P304

Q35664128-DFD9886F-B916-40CA-BA7D-32A6CFC76E2F

P31

Q35664128-80A9C30A-0217-4977-BA3B-0611D2883A17

P356

Q35664128-8A738D7C-3B40-4616-8731-17BB90F1D8CD

P433

Q35664128-BF2F6F95-C213-400F-B5BD-10EA25FA6F86

P478

Q35664128-B0F7CD88-73A6-4F2C-A15A-5F0E9537D30E

P577

Q35664128-115CA717-5986-45A0-A2CA-FD7EFAFD5D49

P5875

Q35664128-09E8BFA8-6066-4666-A1DD-050670F766C6

P698

Q35664128-01C159D4-AD58-476C-870A-35F99F8CF51B

P932

Q35664128-9561CF2A-4B70-4C6F-85DF-C9143F9E1E35

P356

J.NANO.2011.05.010

P1433

Nanomedicine: Nanotechnology, Biology and Medicine

P1476

Cross-linked antioxidant nanozymes for improved delivery to CNS

@en

P2093

Alexander V Kabanov

http://www.w3.org/2001/XMLSchema#string

Anna M Brynskikh

http://www.w3.org/2001/XMLSchema#string

Devika S Manickam

http://www.w3.org/2001/XMLSchema#string

Elena V Batrakova

http://www.w3.org/2001/XMLSchema#string

Natalia L Klyachko

http://www.w3.org/2001/XMLSchema#string

Sheila M Higginbotham

http://www.w3.org/2001/XMLSchema#string

Shu Li

http://www.w3.org/2001/XMLSchema#string

Svetlana V Uglanova

http://www.w3.org/2001/XMLSchema#string

Tatiana K Bronich

http://www.w3.org/2001/XMLSchema#string

P2860

Renal clearance of quantum dots.

Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)

Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats

Loading PEG-catalase into filamentous and spherical polymer nanocarriers.

Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots.

A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.

Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale.

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

Neuroprotective peptide drug delivery and development: potential new therapeutics.

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

P304

119-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NANO.2011.05.010

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51248627

http://www.w3.org/2001/XMLSchema#string

P698

21703990

http://www.w3.org/2001/XMLSchema#string

P932

3255173

http://www.w3.org/2001/XMLSchema#string